Pure Global

Blood gas syringe/needle, lithium heparin - ARTG 400441

Access comprehensive regulatory information for Blood gas syringe/needle, lithium heparin in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 400441 and sponsored by Smiths Medical Australasia Pty Ltd, manufactured by Smiths Medical ASD Inc in United States of America. The device registration started on December 01, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 400441
Class IIa
Blood gas syringe/needle, lithium heparin
ARTG ID: 400441
Good Name: Smiths Medical Australasia Pty Ltd - Blood gas syringe/needle, lithium heparin
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

A sterile plastic syringe with plunger, and a pre-attached needle, that may contain the anticoagulant lithium heparin and is intended to be used for the collection, and preservation and/or transport, of blood for blood gas determination and/or other investigation. The needle is typically removed after sampling and replaced with a cap or stopper for transport. This is a single-use device.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
400441
Start Date
December 01, 2022
Effective Date
December 01, 2022
Manufacturer
Country
United States of America
Address
6000 Nathan Lane North , Minneapolis, MN, 55442